deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04586621

Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects

Sponsor: ABEYE

Conditions Dyslexia
Interventions Atoldys/ Lexilens - SHAM SHAM- Atoldys/ Lexilens
Updated 6 times since 2020 Last updated: Feb 11, 2022 Started: Jan 19, 2021 Primary completion: Jun 29, 2021 Completion: Jun 29, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04586621, this NA trial focuses on Dyslexia and remains completed. Sponsored by ABEYE, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Mar 2022 · 11 months · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. Apr 2021 — Mar 2022 [monthly]

    Recruiting NA

  5. Jan 2021 — Apr 2021 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

  1. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ABEYE
  • Slb Pharma
Data source: ABEYE

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations